January 29th, 2013
Popular Antidepressants May Prolong QT Interval
Larry Husten, PHD
In August 2011 the FDA issued a safety communication recommending that the extremely popular antidepressant citalopram (Celexa) not be used at doses greater than 40 mg/day because of a potential increased risk for serious cardiac arrhythmias associated with prolongation of the QT interval. Now a study published in BMJ lends support to this warning and suggests that other antidepressants may […]
December 1st, 2010
Study Links Tricyclic Antidepressants to Increased Risk for CVD
Larry Husten, PHD
A survey from Scotland has found an increased risk for cardiovascular disease in people taking tricyclic antidepressants (TCAs). In an article in the European Heart Journal, the researchers write that they failed to find any increased risk with selective serotonin reuptake inhibitors (SSRIs). Nearly 15,000 Scottish adults without known histories of CVD were followed for 8 […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy